Aprea Therapeutics Inc (APRE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -122.688 | -34.208 | -28.112 | -47.24 | -49.626 | -259.056 | -54.111 |
Return on Equity (%) | 84.943 | 35.614 | -77.079 | -53.044 | -58.513 | -299.828 | -67.078 |
Return on Invested Capital (%) | -154.948 | -40.406 | -31.871 | -52.389 | -59.043 | -296.71 | -68.492 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -2450.6 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -2450.6 |
Book Value Per Share | 3.647 | 7.153 | 4.306 | 2.667 | 1.668 | 2.571 | 1.625 |
Earnings Per Share | -2.707 | -1.816 | -0.973 | -1.843 | -1.251 | -10.746 | -1.271 |
Cash Per Share | 4.349 | 7.682 | 4.509 | 3.068 | 1.788 | 2.746 | 1.922 |
Working Capital Per Share | 3.641 | 7.151 | 4.297 | 2.657 | 1.66 | 2.571 | 1.614 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.052 |
EBIT Per Share | -2.707 | -1.816 | -0.973 | -1.843 | -1.251 | -10.746 | -1.271 |
EBITDA Per Share | -2.707 | -1.816 | -0.973 | -1.843 | -1.251 | -10.746 | -1.271 |
Free Cash Flow Per Share | -2.709 | -1.817 | -0.977 | -1.843 | -1.251 | -10.746 | -1.263 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 719k | 720k | 21,02M | 21,19M | 21,86M | 2,66M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 2,66M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -737.533 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -737.533 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 17,55M |
Ratio cours/bénéfice | -1,15 |
Ratio prix/ventes | 28,15 |
Ratio prix/liquidités | 0,76 |
Ratio prix/valeur comptable | 0,9 |
Rendement de dividende | - |
Actions en circulation | 5,43M |
Volume moyen (1 semaine) | 21,26k |
Volume moyen (1 mois) | 22,15k |
Variation sur 52 semaines | -21,99% |
Plus haut sur 52 semaines | 8,8465 |
Plus bas sur 52 semaines | 2,1501 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales